Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma,Radiology and Oncology

当前位置： X-MOL 学术 › Radiol. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma
Radiology and Oncology ( IF 2.1 ) Pub Date : 2020-12-03 , DOI: 10.2478/raon-2020-0070
Cuimeng Tian _{1,

2} , Guimei Liu ₁ , Yongxiang Xu ₁ , Guangrong Xia ₁ , Tongmei Zhang ₃ , Jiaqiang Huang ₄ , Hui Jiang ₅ , Ji Ming Wang ₂ , Baolan Li ₃

Affiliation

The beneficial effect of postoperative radiotherapy (PORT) on completely resected pathological IIIA-N2 (pIIIA-N2) non-small cell lung cancer (NSCLC) has been a subject of interest with controversy. The aim of the study was to distinguish the clinical efficacy of PORT on lung adenocarcinoma (LADC) and lung squamous cell carcinoma (LSCC) among pIIIA-N2 NSCLC.

中文翻译：

完全切除病理IIIA-N2期非小细胞肺癌患者术后放疗：鳞状细胞癌的优惠

术后放疗 (PORT) 对完全切除的病理性 IIIA-N2 (pIIIA-N2) 非小细胞肺癌 (NSCLC) 的有益作用一直是一个有争议的话题。该研究的目的是区分 PORT 对 pIIIA-N2 NSCLC 中肺腺癌 (LADC) 和肺鳞状细胞癌 (LSCC) 的临床疗效。

更新日期：2021-01-21

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11